Evidence Hub

Diffuse Alveolar Hemorrhage Due to Macrolide-Refractory Mycoplasma pneumoniae Diagnosed by FilmArray Analysis of Bronchoalveolar Lavage Fluid

T. Nakashima, Toyoshi Yanagihara, Rei Sanai, Yuta Fujimoto, Akira Nakao, Shundo Yuki, Naoki Hamada, N. Ebi et al.

Cureus, 2024

1 citation

Abstract

Mycoplasma pneumoniae typically causes mild respiratory infections but can rarely lead to severe complications. We report a case of a 43-year-old immunocompetent male who presented with progressive dyspnea and respiratory failure with bilateral pulmonary infiltrates, refractory to outpatient treatment with azithromycin, ceftriaxone, and levofloxacin. Bronchoscopy revealed multiple white plaques in the trachea and diffuse alveolar hemorrhage. Although initial throat loop-mediated isothermal amplification (LAMP) testing for M. pneumoniae was negative, FilmArray analysis of bronchoalveolar lavage fluid successfully detected M. pneumoniae. The patient improved with minocycline and methylprednisolone treatment. This case demonstrates that M. pneumoniae can cause severe complications, including diffuse alveolar hemorrhage, even in immunocompetent patients. In some cases, it highlights the importance of lower respiratory tract sampling for accurate diagnosis.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free